NL-OMON35750已完成2 期
Evaluation of the Glucoregulatory Effects of GLP-1 Receptor Activation in Patients with Type 2 Diabetes Mellitus - Glucose-dependent insulin secretion in type II diabetes mellitus
PRA International EDS0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Male, 18-65 years, inclusive
- •BMI is less than or equal to 38.0 kg/m2
- •Type 2 Diabetes Mellitus Patient
排除标准
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study or in case of donating more than 1.5 liter of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
The efficacy of GLP-1 receptor agonist on glycemic control in type 2 diabetes with inadequate DPP-4 inhibitor therapy.type 2 diabetesJPRN-UMIN000006959Department of Metabolism and Endocrinology, Juntendo Graduate University of Medicine90
已完成
不适用
Investigation of the effect of endogenous GLP-1 on cardiac function in chronic heart failurePatients with chronic heart failureJPRN-UMIN000009361Gifu University100
已完成
不适用
GLP-1 analogue therapy on glycemic control in patients undergoing cardiac surgerytype2 diabetesJPRN-UMIN000008003GLOLIA investigation group70
已完成
不适用
Effects of Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) on insulin secretion and energy balance in human obesity and diabetesutritional, Metabolic, Endocrine: DiabetesNutritional, Metabolic, EndocrineDiabetesISRCTN19339824Record Provided by the NHSTCT Register - 2006 Update - Department of Health6
进行中（未招募）
1 期
GLP-1 and persons without stroke.EUCTR2016-001221-14-DKHerlev Gentofte Hospital